22NW Fund GP, LLC, 10% Owner at LIFECORE BIOMEDICAL, INC. \DE\ (LFCR), sold 12,334 shares at $7.00 ($86K) on 2025-05-13, disclosed to the SEC on 2025-05-16.
Open-market sale of $86k LFCR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| CULP | BUY | 2024-09-19 | $2.9M | — | Filing → |
| CULP | BUY | 2024-07-10 | $297K | — | Filing → |
| DRTT | BUY | 2021-08-05 | $13.7M | — | Filing → |